BV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BV, covering 2022-04-07 to 2022-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of BV With Tislelizumab for the Treatment of CD30+ Relapsed/Refractory NK/T-cell Lymphoma [Phase 2]